Medical Technology & Digital Health Analyst Thibault holds a meeting with management in New York on May 12 hosted by BTIG.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ATRC:
- AtriCure’s Strong Q1: Revenue Growth and Challenges
- AtriCure price target lowered to $58 from $60 at UBS
- AtriCure price target lowered to $52 from $58 at BTIG
- AtriCure price target lowered to $51 from $52 at Canaccord
- Atricure’s Strong Q1 2025 Performance and Conservative Guidance Justifies Buy Rating Despite Price Target Adjustment